nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCC2—Carboplatin—ocular cancer	0.201	0.673	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—ocular cancer	0.0974	0.327	CbGbCtD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—CDK2—ocular cancer	0.000692	0.000986	CbGpPWpGaD
Lovastatin—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—ocular cancer	0.000689	0.000981	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SF3B1—ocular cancer	0.000674	0.00096	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—HDAC1—ocular cancer	0.000671	0.000956	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—HRAS—ocular cancer	0.000662	0.000944	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—EP300—ocular cancer	0.000661	0.000942	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PSPH—ocular cancer	0.000655	0.000934	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.000654	0.000932	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—EP300—ocular cancer	0.000654	0.000931	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000652	0.000929	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—TGFB1—ocular cancer	0.000647	0.000921	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.000646	0.00092	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—MYC—ocular cancer	0.000643	0.000916	CbGpPWpGaD
Lovastatin—HDAC2—Transcription—HDAC1—ocular cancer	0.000638	0.000909	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.000618	0.000881	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.000612	0.000872	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—MDM2—ocular cancer	0.00061	0.000869	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—TP53—ocular cancer	0.000599	0.000853	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.000594	0.000847	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—MYC—ocular cancer	0.00059	0.00084	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.000588	0.000838	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—TGFB1—ocular cancer	0.000588	0.000838	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—AKT1—ocular cancer	0.000585	0.000833	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.000583	0.00083	CbGpPWpGaD
Lovastatin—HMGCR—PPARA activates gene expression—EP300—ocular cancer	0.000576	0.000821	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—MYC—ocular cancer	0.00057	0.000812	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000567	0.000807	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000564	0.000803	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000558	0.000795	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—CDKN1B—ocular cancer	0.000557	0.000794	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—RB1—ocular cancer	0.000555	0.000792	CbGpPWpGaD
Lovastatin—HDAC2—Hedgehog signaling events mediated by Gli proteins—AKT1—ocular cancer	0.00054	0.00077	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HDAC1—ocular cancer	0.000538	0.000766	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PSPH—ocular cancer	0.000534	0.000761	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000523	0.000745	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.000518	0.000738	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—CDKN1A—ocular cancer	0.000514	0.000733	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000513	0.000731	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.000513	0.00073	CbGpPWpGaD
Lovastatin—HMGCR—SREBP signalling—AKT1—ocular cancer	0.000506	0.00072	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—AKT1—ocular cancer	0.000506	0.00072	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—CCND1—ocular cancer	0.000504	0.000718	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—EP300—ocular cancer	0.000489	0.000697	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000486	0.000692	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—CDK4—ocular cancer	0.000478	0.000682	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—MDM2—ocular cancer	0.000477	0.000679	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—EIF1AX—ocular cancer	0.000475	0.000676	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—MDM2—ocular cancer	0.000474	0.000675	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—EP300—ocular cancer	0.000464	0.000661	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PSPH—ocular cancer	0.000454	0.000647	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—CDK4—ocular cancer	0.00045	0.000641	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000447	0.000637	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—AKT1—ocular cancer	0.000446	0.000636	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—EP300—ocular cancer	0.000442	0.00063	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CDKN1B—ocular cancer	0.000435	0.00062	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—MYC—ocular cancer	0.00043	0.000612	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TGFB1—ocular cancer	0.000425	0.000606	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.000417	0.000594	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SAG—ocular cancer	0.000414	0.00059	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—AKT1—ocular cancer	0.000409	0.000583	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—GNA11—ocular cancer	0.000407	0.000579	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—MYC—ocular cancer	0.000404	0.000576	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CDKN1A—ocular cancer	0.000402	0.000572	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—CDKN1A—ocular cancer	0.000399	0.000569	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PSPH—ocular cancer	0.000396	0.000564	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—E2F5—ocular cancer	0.000395	0.000563	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00039	0.000555	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—EP300—ocular cancer	0.000389	0.000554	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000388	0.000554	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—E2F4—ocular cancer	0.000387	0.000551	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TGFB1—ocular cancer	0.000384	0.000547	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—EP300—ocular cancer	0.00038	0.000541	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—RPL39—ocular cancer	0.000379	0.000541	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—RBL1—ocular cancer	0.000379	0.000541	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—GNAQ—ocular cancer	0.000378	0.000539	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PSPH—ocular cancer	0.000369	0.000526	CbGpPWpGaD
Lovastatin—HDAC2—Disease—E2F5—ocular cancer	0.000367	0.000523	CbGpPWpGaD
Lovastatin—HDAC2—Disease—E2F4—ocular cancer	0.000359	0.000512	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000356	0.000507	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RPL39—ocular cancer	0.000352	0.000502	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RBL1—ocular cancer	0.000352	0.000502	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.000352	0.000502	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TP53—ocular cancer	0.00035	0.000499	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HDAC1—ocular cancer	0.000341	0.000486	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PSPH—ocular cancer	0.000338	0.000482	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—TP53—ocular cancer	0.000332	0.000473	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—RBBP4—ocular cancer	0.000329	0.000469	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—TGFB1—ocular cancer	0.000325	0.000464	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000324	0.000461	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00032	0.000456	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TP53—ocular cancer	0.000316	0.000451	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PSPH—ocular cancer	0.00031	0.000442	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—TFDP1—ocular cancer	0.000306	0.000436	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—HRAS—ocular cancer	0.000302	0.000431	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—CCND1—ocular cancer	0.000291	0.000414	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SAG—ocular cancer	0.00029	0.000413	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—MDM2—ocular cancer	0.000289	0.000412	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—EP300—ocular cancer	0.000284	0.000405	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TFDP1—ocular cancer	0.000284	0.000405	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—ocular cancer	0.000278	0.000396	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—TGFB1—ocular cancer	0.000277	0.000394	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—ocular cancer	0.000272	0.000387	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00027	0.000385	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—MDM2—ocular cancer	0.000267	0.000381	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—EP300—ocular cancer	0.000267	0.000381	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—AKT1—ocular cancer	0.000267	0.000381	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CDKN1B—ocular cancer	0.000264	0.000376	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HRAS—ocular cancer	0.000262	0.000373	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—E2F5—ocular cancer	0.000257	0.000366	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—E2F4—ocular cancer	0.000252	0.000358	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000248	0.000353	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RBL1—ocular cancer	0.000247	0.000352	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—CDKN1B—ocular cancer	0.000244	0.000348	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CDKN1A—ocular cancer	0.000244	0.000347	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MAML2—ocular cancer	0.000243	0.000346	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—CDK2—ocular cancer	0.000242	0.000345	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EP300—ocular cancer	0.000232	0.00033	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—AKT1—ocular cancer	0.000231	0.000329	CbGpPWpGaD
Lovastatin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00023	0.000327	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAML2—ocular cancer	0.000226	0.000321	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—CDKN1A—ocular cancer	0.000225	0.000321	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—TGFB1—ocular cancer	0.000225	0.00032	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PSPH—ocular cancer	0.000224	0.00032	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000224	0.000319	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—TGFB1—ocular cancer	0.000219	0.000313	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000215	0.000307	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—E2F3—ocular cancer	0.000214	0.000305	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GNA11—ocular cancer	0.000206	0.000294	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—ocular cancer	0.000203	0.00029	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TFDP1—ocular cancer	0.000199	0.000283	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000198	0.000281	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PSPH—ocular cancer	0.000194	0.000277	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GNAQ—ocular cancer	0.000192	0.000273	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—HDAC1—ocular cancer	0.000178	0.000253	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PSPH—ocular cancer	0.000173	0.000247	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00017	0.000243	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PSPH—ocular cancer	0.000169	0.000241	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000169	0.00024	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GNA11—ocular cancer	0.000168	0.00024	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HDAC1—ocular cancer	0.000165	0.000235	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000161	0.000229	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PSPH—ocular cancer	0.00016	0.000227	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—CDKN2B—ocular cancer	0.000159	0.000227	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HRAS—ocular cancer	0.000159	0.000226	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PSPH—ocular cancer	0.000158	0.000225	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAML2—ocular cancer	0.000158	0.000225	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GNAQ—ocular cancer	0.000156	0.000223	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000155	0.00022	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN2B—ocular cancer	0.000148	0.000211	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HRAS—ocular cancer	0.000147	0.000209	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GNA11—ocular cancer	0.000143	0.000204	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—AKT1—ocular cancer	0.00014	0.0002	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNA11—ocular cancer	0.000138	0.000196	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—EP300—ocular cancer	0.000136	0.000194	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000135	0.000193	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GNAQ—ocular cancer	0.000133	0.000189	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—AKT1—ocular cancer	0.00013	0.000185	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNAQ—ocular cancer	0.000128	0.000183	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GNA11—ocular cancer	0.000124	0.000177	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000119	0.00017	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—ocular cancer	0.000118	0.000168	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GNA11—ocular cancer	0.000116	0.000166	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GNAQ—ocular cancer	0.000116	0.000165	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HDAC1—ocular cancer	0.000116	0.000165	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000109	0.000155	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GNAQ—ocular cancer	0.000108	0.000154	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GNA11—ocular cancer	0.000106	0.000152	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PSPH—ocular cancer	0.000104	0.000149	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000104	0.000148	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN2B—ocular cancer	0.000104	0.000148	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000101	0.000143	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GNAQ—ocular cancer	9.9e-05	0.000141	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GNA11—ocular cancer	9.77e-05	0.000139	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—ocular cancer	9.72e-05	0.000139	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	9.57e-05	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—E2F1—ocular cancer	9.5e-05	0.000135	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.34e-05	0.000133	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—ocular cancer	9.3e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GNAQ—ocular cancer	9.08e-05	0.000129	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	8.34e-05	0.000119	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	8.32e-05	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—ocular cancer	8.21e-05	0.000117	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MDM2—ocular cancer	8.2e-05	0.000117	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.99e-05	0.000114	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN1B—ocular cancer	7.49e-05	0.000107	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GNA11—ocular cancer	7.06e-05	0.000101	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN1A—ocular cancer	6.91e-05	9.85e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—EP300—ocular cancer	6.89e-05	9.82e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	6.85e-05	9.76e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EP300—ocular cancer	6.58e-05	9.37e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GNAQ—ocular cancer	6.56e-05	9.35e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—ocular cancer	6.17e-05	8.8e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNA11—ocular cancer	6.12e-05	8.72e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	5.78e-05	8.24e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MDM2—ocular cancer	5.74e-05	8.18e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—ocular cancer	5.73e-05	8.17e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—ocular cancer	5.72e-05	8.15e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNAQ—ocular cancer	5.69e-05	8.1e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—EP300—ocular cancer	5.62e-05	8e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNA11—ocular cancer	5.46e-05	7.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNA11—ocular cancer	5.33e-05	7.59e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1B—ocular cancer	5.24e-05	7.47e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNAQ—ocular cancer	5.08e-05	7.23e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNA11—ocular cancer	5.02e-05	7.15e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—ocular cancer	5e-05	7.13e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNA11—ocular cancer	4.98e-05	7.09e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNAQ—ocular cancer	4.95e-05	7.06e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1A—ocular cancer	4.84e-05	6.9e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—EP300—ocular cancer	4.78e-05	6.8e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNAQ—ocular cancer	4.67e-05	6.65e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNAQ—ocular cancer	4.63e-05	6.59e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EP300—ocular cancer	4.61e-05	6.56e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.59e-05	6.54e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—ocular cancer	4.5e-05	6.41e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—ocular cancer	4.28e-05	6.1e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—ocular cancer	4.16e-05	5.93e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—EP300—ocular cancer	4.16e-05	5.93e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.1e-05	5.84e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—ocular cancer	4.01e-05	5.72e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—ocular cancer	4e-05	5.7e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—ocular cancer	3.97e-05	5.66e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—EP300—ocular cancer	3.88e-05	5.53e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.73e-05	5.32e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—EP300—ocular cancer	3.56e-05	5.07e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—ocular cancer	3.39e-05	4.84e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—ocular cancer	3.3e-05	4.7e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNA11—ocular cancer	3.28e-05	4.68e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—EP300—ocular cancer	3.26e-05	4.65e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—ocular cancer	3.15e-05	4.49e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNAQ—ocular cancer	3.05e-05	4.35e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—ocular cancer	2.89e-05	4.11e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—ocular cancer	2.78e-05	3.97e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—ocular cancer	2.51e-05	3.58e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—EP300—ocular cancer	2.36e-05	3.36e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—ocular cancer	2.35e-05	3.34e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—ocular cancer	2.15e-05	3.06e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—EP300—ocular cancer	2.04e-05	2.91e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—ocular cancer	1.97e-05	2.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—EP300—ocular cancer	1.82e-05	2.6e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—EP300—ocular cancer	1.78e-05	2.54e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—EP300—ocular cancer	1.68e-05	2.39e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—EP300—ocular cancer	1.66e-05	2.37e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—ocular cancer	1.43e-05	2.03e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—ocular cancer	1.23e-05	1.76e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—ocular cancer	1.1e-05	1.57e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—EP300—ocular cancer	1.1e-05	1.56e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—ocular cancer	1.08e-05	1.53e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—ocular cancer	1.01e-05	1.44e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—ocular cancer	1.01e-05	1.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—ocular cancer	6.63e-06	9.44e-06	CbGpPWpGaD
